Abattis Bioceuticals is a public company traded on the CSE in Canada and through the OTC market in the United States.

Abattis Bioceuticals Corp. is a life sciences company which aggregates, integrates, and invests in biotechnology services internationally. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. The Company follows strict standard operating protocols and adheres to applicable laws of Canada and foreign jurisdictions.

Stock Exchanges and Trading:

OTC (United States): ATTBF
CSE (Canada): ATT

Latest Company filings can be found on SEDAR

Fiscal Year End: 9/30
SIC – Industry Class: 2833 – medicinal and botanicals
Incorporated In: British Columbia, Canada
Year of Inc.: 1997


  • Robert Abenante – President & CEO
  • Francesco Paolini – CFO
  • Patrick Mitchell – COO



  • Robert Abenante – Director
  • Francesco Paolini – Director
  • Patrick Mitchell – Director
  • Cedric Wilson – Director



NVS Chartered Accountants Professional Corporation


Legal Counsel

Clark Wilson LLP


Transfer Agent

Computershare Investor Services Inc.